Der gegen das Protein PD-1 gerichtete Antikörper Cemiplimab bewährt sich in der Phase-II-Studie EMPOWER-cSCC 1. … lesen Sie weiter! Quelle: : http://www.aerztezeitung.de/medizin/krankheiten/krebs/hautkrebs/article/954819/hautkrebs-erfolg-cemiplimab-kutanem-plattenepithelkarzinom.html
Related Posts
Important update to Easter list – product removed
Important update to Easter list – product removed … lesen Sie weiter! Quelle: : https://www.coeliac.org.uk/about-us/news/important-update-to-easter-list-product-removed
HNO 2017: Current Progress in Neurolaryngology
Laryngeal Pacing for BVFP BVFP (bilateral vocal fold paralysis) refers to neurological causes of reduced or absent movement of both vocal folds. It is characterized by inspiratory dyspnea due to narrowing of the airway at the glottic level with… …
Travelling by car to our AGM?
Please note the directions by car on the recent AGM notice should say M4, junction 11. … lesen Sie weiter! Quelle: : https://www.coeliac.org.uk/about-us/news/travelling-by-car-to-our-agm